- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/55 - Protease inhibitors
Patent holdings for IPC class A61K 38/55
Total number of patents in this class: 673
10-year publication summary
|
45
|
35
|
41
|
40
|
36
|
43
|
44
|
36
|
43
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| CSL Behring GmbH | 344 |
18 |
| Entera Bio Ltd. | 47 |
12 |
| The Regents of the University of California | 20035 |
11 |
| The Johns Hopkins University | 5700 |
11 |
| Mondobiotech Laboratories AG | 311 |
11 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
10 |
| Daiichi Sankyo Company, Limited | 1886 |
9 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2880 |
9 |
| Oramed Ltd. | 26 |
9 |
| Centre National de La Recherche Scientifique | 10498 |
7 |
| Massachusetts Eye and Ear Infirmary | 382 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6447 |
6 |
| The General Hospital Corporation | 4759 |
6 |
| Takeda Pharmaceutical Company Limited | 2707 |
6 |
| Société des Produits Nestlé S.A. | 9311 |
5 |
| The Trustees of Columbia University in the City of New York | 3584 |
5 |
| University of Florida Research Foundation, Inc. | 4044 |
5 |
| Kamada Ltd. | 58 |
5 |
| Rani Therapeutics, LLC | 200 |
5 |
| Serpin Pharma, LLC | 21 |
5 |
| Other owners | 511 |